X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (271) 271
index medicus (261) 261
warfarin (222) 222
non-vitamin k antagonist oral anticoagulants (204) 204
humans (187) 187
anticoagulants (155) 155
cardiac & cardiovascular systems (145) 145
dabigatran (144) 144
stroke (134) 134
rivaroxaban (120) 120
administration, oral (108) 108
atrial fibrillation - drug therapy (101) 101
aged (91) 91
female (90) 90
male (89) 89
apixaban (84) 84
anticoagulants - administration & dosage (82) 82
anticoagulants - therapeutic use (82) 82
stroke prevention (79) 79
risk (75) 75
anticoagulants - adverse effects (72) 72
anticoagulation (72) 72
vitamin k antagonists (71) 71
stroke - prevention & control (68) 68
safety (66) 66
risk factors (63) 63
atrial fibrillation - complications (60) 60
non-vitamin k oral anticoagulants (59) 59
non-vitamin k antagonist oral anticoagulant (58) 58
oral anticoagulants (58) 58
edoxaban (56) 56
treatment outcome (56) 56
prevention (53) 53
antithrombotic therapy (52) 52
bleeding (52) 52
hemorrhage - chemically induced (52) 52
middle aged (52) 52
management (51) 51
venous thromboembolism (51) 51
thromboembolism (50) 50
cardiac arrhythmia (49) 49
peripheral vascular disease (49) 49
therapy (48) 48
aged, 80 and over (46) 46
efficacy (45) 45
cardiology (43) 43
pharmacology & pharmacy (43) 43
medicine, general & internal (42) 42
vitamin k - antagonists & inhibitors (42) 42
atrial-fibrillation (41) 41
hematology (41) 41
medicine & public health (41) 41
stroke - etiology (39) 39
vitamin k (35) 35
atrial fibrillation - diagnosis (32) 32
intracranial hemorrhage (31) 31
metaanalysis (31) 31
retrospective studies (30) 30
catheter ablation (29) 29
fibrillation (29) 29
mortality (28) 28
analysis (27) 27
thromboembolism - prevention & control (27) 27
vitamin-k antagonists (27) 27
care and treatment (26) 26
internal medicine (26) 26
oral anticoagulation (26) 26
outcomes (26) 26
review (26) 26
noacs (25) 25
warfarin - adverse effects (25) 25
patients (24) 24
dabigatran - therapeutic use (23) 23
direct oral anticoagulants (23) 23
drug therapy (23) 23
aspirin (22) 22
factor xa inhibitor (22) 22
rivaroxaban - therapeutic use (22) 22
atrial fibrillation - epidemiology (21) 21
clinical trials (21) 21
guidelines (21) 21
percutaneous coronary intervention (21) 21
thrombosis (21) 21
abridged index medicus (20) 20
cardiovascular (20) 20
hemorrhage (20) 20
major bleeding (20) 20
nonvalvular atrial-fibrillation (20) 20
time factors (20) 20
vitamin k antagonist (20) 20
warfarin - therapeutic use (20) 20
adherence (19) 19
dabigatran etexilate (19) 19
risk assessment (19) 19
atrial fibrillation - therapy (18) 18
clinical neurology (18) 18
dabigatran - adverse effects (18) 18
dosage and administration (18) 18
incidence (18) 18
pyrazoles - therapeutic use (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (408) 408
German (18) 18
Japanese (18) 18
Russian (4) 4
French (3) 3
Hungarian (2) 2
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 03/2017, Volume 135, Issue 10, pp. e604 - e633
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 07/2017, Volume 39, Issue 7, pp. 1456 - 1478.e36
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2019, Volume 119, Issue 1, pp. 14 - 38
Journal Article
EP Europace, ISSN 1099-5129, 08/2018, Volume 20, Issue 8, pp. 1231 - 1242
Journal Article
Journal Article
by Deng, YQ and Tong, YF and Deng, YY and Zou, L and Li, SH and Chen, H
JOURNAL OF THE AMERICAN HEART ASSOCIATION, ISSN 2047-9980, 07/2019, Volume 8, Issue 14, p. e012540
Background-Several studies have investigated the effect of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with... 
CARDIAC & CARDIOVASCULAR SYSTEMS | non-vitamin K antagonist oral anticoagulants | CHADS-VASC SCORE | RIVAROXABAN | RISK | efficacy | warfarin | PREDICTION | STROKE | atrial fibrillation | MALIGNANCY | DABIGATRAN | safety | ANTITHROMBOTIC THERAPY | cancer | THROMBOEMBOLISM | EPIDEMIOLOGY
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 06/2019, Volume 50, Issue 6, pp. 1480 - 1489
BACKGROUND AND PURPOSE—In clinical trials, the reduced efficacy of non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention was reported for... 
STROKE PREVENTION | EFFICACY | SAFETY | anticoagulation | AF-TIMI 48 | EDOXABAN | creatinine clearance | APIXABAN | stroke | CLINICAL NEUROLOGY | non-vitamin K | warfarin | ATRIAL-FIBRILLATION | atrial fibrillation | PROPENSITY SCORE METHODS | POPULATION PHARMACOKINETICS | antagonist oral anticoagulant | PERIPHERAL VASCULAR DISEASE | Anticoagulants - administration & dosage | Humans | Male | Gastrointestinal Hemorrhage - mortality | Atrial Fibrillation - physiopathology | Stroke - physiopathology | Kidney Function Tests | Vitamin K - antagonists & inhibitors | Stroke - chemically induced | Atrial Fibrillation - mortality | Intracranial Hemorrhages - mortality | Aged, 80 and over | Female | Retrospective Studies | Brain Ischemia - chemically induced | Stroke - mortality | Republic of Korea - epidemiology | Intracranial Hemorrhages - physiopathology | Administration, Oral | Atrial Fibrillation - drug therapy | Gastrointestinal Hemorrhage - physiopathology | Risk Factors | Brain Ischemia - physiopathology | Anticoagulants - adverse effects | Gastrointestinal Hemorrhage - chemically induced | Asian Continental Ancestry Group | Intracranial Hemorrhages - chemically induced | Aged | Brain Ischemia - mortality | Kidneys | Atrial fibrillation | Patient outcomes | Anticoagulants (Medicine) | Drug therapy | Comparative analysis | Health aspects | Asians
Journal Article